Fiscal Period | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Period End Date | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
Revenue | 238.78 | 137.25 | 252.96 | 76.81 |
Total Revenue | 238.78 | 137.25 | 252.96 | 76.81 |
Costof Revenue Total | 34.32 | 30.70 | 36.70 | 57.02 |
Gross Profit | 204.46 | 106.55 | 216.26 | 19.80 |
Selling/ General/ Admin Expenses Total | 412.84 | 290.89 | 347.56 | 323.00 |
Depreciation/ Amortization | 11.77 | 10.16 | 10.92 | 9.48 |
Other Operating Expenses Total | 3.50 | 1.57 | 3.48 | 2.27 |
Total Operating Expense | 462.42 | 333.32 | 398.66 | 391.77 |
Operating Income | -223.64 | -196.07 | -145.70 | -314.95 |
Interest Inc( Exp) Net- Non- Op Total | 11.57 | -124.81 | -61.72 | 18.60 |
Gain( Loss)on Saleof Assets | -0.96 | 48.93 | 2.64 | 0.00 |
Net Income Before Taxes | -222.58 | -203.40 | -151.14 | -312.40 |
Provisionfor Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income After Taxes | -222.58 | -203.40 | -151.14 | -312.40 |
Net Income Before Extra Items | -222.58 | -203.40 | -151.14 | -312.40 |
Net Income | -222.58 | -203.40 | -151.14 | -312.40 |
Income Availableto Com Excl Extra Ord | -222.58 | -203.40 | -151.14 | -312.40 |
Income Availableto Com Incl Extra Ord | -222.58 | -203.40 | -151.14 | -312.40 |
Diluted Net Income | -222.58 | -203.40 | -151.14 | -312.40 |
Diluted Weighted Average Shares | 28.47 | 26.31 | 26.20 | 26.20 |
Diluted EPS Excluding Extra Ord Items | -7.82 | -7.73 | -5.77 | -11.92 |
Diluted Normalized EPS | -7.81 | -7.92 | -5.78 | -11.92 |
Other Net | - | 0.27 | 0.47 | 0.69 |
Sun Pharma Advanced Research Com Dividend | Sun Pharma Advanced Research Com Bonus | Sun Pharma Advanced Research Com News | Sun Pharma Advanced Research Com AGM | Sun Pharma Advanced Research Com Rights | Sun Pharma Advanced Research Com Splits | Sun Pharma Advanced Research Com Board Meetings | Sun Pharma Advanced Research Com Key Metrics | Sun Pharma Advanced Research Com Shareholdings | Sun Pharma Advanced Research Com Balance Sheet | Sun Pharma Advanced Research Com Cashflow | Sun Pharma Advanced Research Com Q1 Results | Sun Pharma Advanced Research Com Q2 Results | Sun Pharma Advanced Research Com Q3 Results | Sun Pharma Advanced Research Com Q4 Results
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks